FDA
-
-
-
-
-
-
-
Itamar Medical Announces Additional 16 Million Covered Lives for WatchPAT™, the Only Single-Use Sleep Apnea Test that Meets Guidelines
-
-
-
-
-
-
-
Itamar™ Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using Existing Big Data and Artificial Intelligence
-
-
-
-
-
-
-
Itamar™ Medical to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 26, 2019
-
-
-
-
-
-
-
Itamar Medical’s WatchPAT™ One, the First and Only Fully Disposable Home Sleep Apnea Test Receives FDA 510(k) Clearance
-
-
-
-
-
-
-
Itamar Medical to Commence Trading on Nasdaq
-
-
-
-
-
-
-
Itamar Medical Launches SleePath™, an Integrated Cloud-based Sleep Apnea Patient Care Pathway Management Tool for AFib Patients at Heart Rhythm 2018
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

